GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Institutional Ownership

Tiziana Life Sciences (Tiziana Life Sciences) Institutional Ownership : 0.22% (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tiziana Life Sciences's institutional ownership is 0.22%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tiziana Life Sciences's Insider Ownership is 72.05%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tiziana Life Sciences's Float Percentage Of Total Shares Outstanding is 60.50%.


Tiziana Life Sciences Institutional Ownership Historical Data

The historical data trend for Tiziana Life Sciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Institutional Ownership Chart

Tiziana Life Sciences Historical Data

The historical data trend for Tiziana Life Sciences can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-04-30
Institutional Ownership 0.20 0.20 0.21 0.21 0.21 0.21 0.21 0.21 0.21 0.22

Tiziana Life Sciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Traded in Other Exchanges
Address
2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.